-
2
-
-
0036138874
-
Proteomic analysis of normal and malignant prostate tissue to identify novel proteins lost in cancer
-
Meehan KL, Holland JW, Dawkins HJS. Proteomic analysis of normal and malignant prostate tissue to identify novel proteins lost in cancer. Prostate. 2002; 50: 54-63.
-
(2002)
Prostate
, vol.50
, pp. 54-63
-
-
Meehan, K.L.1
Holland, J.W.2
Dawkins, H.J.S.3
-
3
-
-
0037120949
-
Serum proteomic patterns for detection of prostate cancer
-
Petricoin EF, 3rd, Ornstein DK, Paweletz CP, et al. Serum proteomic patterns for detection of prostate cancer. J Natl Cancer Inst. 2002; 94: 1576-1578.
-
(2002)
J Natl Cancer Inst
, vol.94
, pp. 1576-1578
-
-
Petricoin, E.F.1
Ornstein, D.K.2
Paweletz, C.P.3
-
4
-
-
27644506613
-
Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression
-
Varambally S, Yu J, Laxman B, et al. Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression. Cancer Cell. 2005; 8: 393-406.
-
(2005)
Cancer Cell
, vol.8
, pp. 393-406
-
-
Varambally, S.1
Yu, J.2
Laxman, B.3
-
5
-
-
36249025664
-
Identification of candidate prostate cancer biomarkers in prostate needle biopsy specimens using proteomic analysis
-
Lin J, Xu J, Tian H, et al. Identification of candidate prostate cancer biomarkers in prostate needle biopsy specimens using proteomic analysis. Int J Cancer. 2007; 121: 2596-2605.
-
(2007)
Int J Cancer
, vol.121
, pp. 2596-2605
-
-
Lin, J.1
Xu, J.2
Tian, H.3
-
6
-
-
53049090352
-
Search for potential markers for prostate cancer diagnosis, prognosis and treatment in clinical tissue specimens using amine-specific isobaric tagging (iTRAQ) with two-dimensional liquid chromatography and tandem mass spectrometry
-
Garbis SD, Tyritzis SI, Roumeliotis T, et al. Search for potential markers for prostate cancer diagnosis, prognosis and treatment in clinical tissue specimens using amine-specific isobaric tagging (iTRAQ) with two-dimensional liquid chromatography and tandem mass spectrometry. J Proteome Res. 2008; 7: 3146-3158.
-
(2008)
J Proteome Res
, vol.7
, pp. 3146-3158
-
-
Garbis, S.D.1
Tyritzis, S.I.2
Roumeliotis, T.3
-
7
-
-
84862979866
-
Identification of potential complementary serum biomarkers to differentiate prostate cancer from benign prostatic hyperplasia using gel-and lectin-based proteomics analyses
-
Jayapalan JJ, Ng KL, Razack AH, et al. Identification of potential complementary serum biomarkers to differentiate prostate cancer from benign prostatic hyperplasia using gel-and lectin-based proteomics analyses. Electrophoresis. 2012; 33: 1855-1862.
-
(2012)
Electrophoresis
, vol.33
, pp. 1855-1862
-
-
Jayapalan, J.J.1
Ng, K.L.2
Razack, A.H.3
-
8
-
-
84857068469
-
iTRAQ identification of candidate serum biomarkers associated with metastatic progression of human prostate cancer
-
Rehman I, Evans CA, Glen A, et al. iTRAQ identification of candidate serum biomarkers associated with metastatic progression of human prostate cancer. PLoS One. 2012; 7: e30885.
-
(2012)
PLoS One
, vol.7
-
-
Rehman, I.1
Evans, C.A.2
Glen, A.3
-
9
-
-
84939176335
-
Proteomics analysis of malignant and benign prostate tissue by 2D DIGE/MS reveals new insights into proteins involved in prostate cancer
-
Davalieva K, Kostovska IM, Kiprijanovska S, et al. Proteomics analysis of malignant and benign prostate tissue by 2D DIGE/MS reveals new insights into proteins involved in prostate cancer. Prostate. 2015; 75: 1586-1600.
-
(2015)
Prostate
, vol.75
, pp. 1586-1600
-
-
Davalieva, K.1
Kostovska, I.M.2
Kiprijanovska, S.3
-
10
-
-
18244392008
-
Proteomic analysis of human prostate cancer
-
Ahram M, Best CJM, Flaig MJ, et al. Proteomic analysis of human prostate cancer. Mol Carcinog. 2002; 33: 9-15.
-
(2002)
Mol Carcinog
, vol.33
, pp. 9-15
-
-
Ahram, M.1
Best, C.J.M.2
Flaig, M.J.3
-
11
-
-
51749123784
-
Apparently low reproducibility of true differential expression discoveries in microarray studies
-
Zhang M, Yao C, Guo Z, et al. Apparently low reproducibility of true differential expression discoveries in microarray studies. Bioinformatics. 2008; 24: 2057-2063.
-
(2008)
Bioinformatics
, vol.24
, pp. 2057-2063
-
-
Zhang, M.1
Yao, C.2
Guo, Z.3
-
12
-
-
84873340345
-
Molecular signature of cancer at gene level or pathway level? Case studies of colorectal cancer and prostate cancer microarray data
-
Chen J, Wang Y, Shen B, et al. Molecular signature of cancer at gene level or pathway level? Case studies of colorectal cancer and prostate cancer microarray data. Comput Math Methods Med. 2013; 2013: 909525.
-
(2013)
Comput Math Methods Med
, vol.2013
-
-
Chen, J.1
Wang, Y.2
Shen, B.3
-
13
-
-
0036682376
-
Meta-analysis of microarrays: Interstudy validation of gene expression profiles reveals pathway dysregulation in prostate cancer
-
Rhodes DR, Barrette TR, Rubin MA, et al. Meta-analysis of microarrays: Interstudy validation of gene expression profiles reveals pathway dysregulation in prostate cancer. Cancer Res. 2002; 62: 4427-4433.
-
(2002)
Cancer Res
, vol.62
, pp. 4427-4433
-
-
Rhodes, D.R.1
Barrette, T.R.2
Rubin, M.A.3
-
14
-
-
26444608611
-
Discovering statistically significant pathways in expression profiling studies
-
Tian L, Greenberg SA, Kong SW, et al. Discovering statistically significant pathways in expression profiling studies. Proc Natl Acad Sci U S A. 2005; 102: 13544-13549.
-
(2005)
Proc Natl Acad Sci U S A
, vol.102
, pp. 13544-13549
-
-
Tian, L.1
Greenberg, S.A.2
Kong, S.W.3
-
15
-
-
33749999763
-
Group testing for pathway analysis improves comparability of different microarray datasets
-
Manoli T, Gretz N, Gröne H, et al. Group testing for pathway analysis improves comparability of different microarray datasets. Bioinformatics. 2006; 22: 2500-2506.
-
(2006)
Bioinformatics
, vol.22
, pp. 2500-2506
-
-
Manoli, T.1
Gretz, N.2
Gröne, H.3
-
16
-
-
57149092133
-
Inferring pathway activity toward precise disease classification
-
Lee E, Chuang HY, Kim JW, et al. Inferring pathway activity toward precise disease classification. PLoS Comput Biol. 2008; 4: e1000217.
-
(2008)
PLoS Comput Biol
, vol.4
-
-
Lee, E.1
Chuang, H.Y.2
Kim, J.W.3
-
17
-
-
79959713125
-
Identifying novel prostate cancer associated pathways based on integrative microarray data analysis
-
Wang Y, Chen J, Li Q, et al. Identifying novel prostate cancer associated pathways based on integrative microarray data analysis. Comput Biol Chem. 2011; 35: 151-158.
-
(2011)
Comput Biol Chem
, vol.35
, pp. 151-158
-
-
Wang, Y.1
Chen, J.2
Li, Q.3
-
18
-
-
52149123619
-
Core signaling pathways in human pancreatic cancers revealed by global genomic analyses
-
Jones S, Zhang X, Parsons DW, et al. Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science. 2008; 321: 1801-1806.
-
(2008)
Science
, vol.321
, pp. 1801-1806
-
-
Jones, S.1
Zhang, X.2
Parsons, D.W.3
-
19
-
-
0003677259
-
-
Atlanta: American Cancer Society
-
American Cancer Society. Cancer facts & figures 2015. Atlanta: American Cancer Society; 2015.
-
(2015)
Cancer facts & figures 2015
-
-
-
20
-
-
0031984026
-
Prostate-specific antigen levels are higher in African-American than in white patients in a multicenter registration study: Results of RTOG 94-12
-
Vijayakumar S, Winter K, Sause W, et al. Prostate-specific antigen levels are higher in African-American than in white patients in a multicenter registration study: Results of RTOG 94-12. Int J Radiat Oncol Biol Phys. 1998; 40: 17-25.
-
(1998)
Int J Radiat Oncol Biol Phys
, vol.40
, pp. 17-25
-
-
Vijayakumar, S.1
Winter, K.2
Sause, W.3
-
21
-
-
84892415984
-
Age and racial differences among PSA-detected (AJCC stage T1cN0M0) prostate cancer in the U.S.: A population-based study of 70,345 men
-
Zhang H, Messing EM, Travis LB, et al. Age and racial differences among PSA-detected (AJCC stage T1cN0M0) prostate cancer in the U.S.: A population-based study of 70,345 men. Front Oncol. 2013; 3: 312.
-
(2013)
Front Oncol
, vol.3
, pp. 312
-
-
Zhang, H.1
Messing, E.M.2
Travis, L.B.3
-
22
-
-
0028865113
-
Prostate-specific antigen values at the time of prostate cancer diagnosis in African-American men
-
Moul JW, Sesterhenn IA, Connelly RR, et al. Prostate-specific antigen values at the time of prostate cancer diagnosis in African-American men. JAMA. 1995; 274: 1277-1281.
-
(1995)
JAMA
, vol.274
, pp. 1277-1281
-
-
Moul, J.W.1
Sesterhenn, I.A.2
Connelly, R.R.3
-
23
-
-
0032323805
-
Prostate specific antigen and pathological features of prostate cancer in black and white patients: A comparative study based on radical prostatectomy specimens
-
Pettaway CA, Troncoso P, Ramirez EI, et al. Prostate specific antigen and pathological features of prostate cancer in black and white patients: A comparative study based on radical prostatectomy specimens. J Urol. 1998; 160: 437-442.
-
(1998)
J Urol
, vol.160
, pp. 437-442
-
-
Pettaway, C.A.1
Troncoso, P.2
Ramirez, E.I.3
-
24
-
-
77950519549
-
Evidence supports a faster growth rate and/or earlier transformation to clinically significant prostate cancer in black than in white American men, and influences racial progression and mortality disparity
-
Powell IJ, Bock CH, Ruterbusch JJ, et al. Evidence supports a faster growth rate and/or earlier transformation to clinically significant prostate cancer in black than in white American men, and influences racial progression and mortality disparity. J Urol. 2010; 183: 1792-1797.
-
(2010)
J Urol
, vol.183
, pp. 1792-1797
-
-
Powell, I.J.1
Bock, C.H.2
Ruterbusch, J.J.3
-
25
-
-
84924290869
-
Predominance of ERG-negative high-grade prostate cancers in African American men
-
Farrell J, Young D, Chen Y, et al. Predominance of ERG-negative high-grade prostate cancers in African American men. Mol Clin Oncol. 2014; 2: 982-986.
-
(2014)
Mol Clin Oncol
, vol.2
, pp. 982-986
-
-
Farrell, J.1
Young, D.2
Chen, Y.3
-
26
-
-
0035819936
-
Racial and ethnic differences in advanced-stage prostate cancer: The prostate cancer outcomes study
-
Hoffman RM, Gilliland FD, Eley JW, et al. Racial and ethnic differences in advanced-stage prostate cancer: The prostate cancer outcomes study. J Natl Cancer Inst. 2001; 93: 388-395.
-
(2001)
J Natl Cancer Inst
, vol.93
, pp. 388-395
-
-
Hoffman, R.M.1
Gilliland, F.D.2
Eley, J.W.3
-
27
-
-
84873745349
-
African-American men with low-grade prostate cancer have higher tumor burdens: Results from the Duke prostate center
-
Tsivian M, Banez LL, Keto CJ, et al. African-American men with low-grade prostate cancer have higher tumor burdens: Results from the Duke prostate center. Prostate Cancer Prostatic Dis. 2013; 16: 91-94.
-
(2013)
Prostate Cancer Prostatic Dis
, vol.16
, pp. 91-94
-
-
Tsivian, M.1
Banez, L.L.2
Keto, C.J.3
-
28
-
-
33745315223
-
African-American men with nonpalpable prostate cancer exhibit greater tumor volume than matched white men
-
Sanchez-Ortiz RF, Troncoso P, Babaian RJ, et al. African-American men with nonpalpable prostate cancer exhibit greater tumor volume than matched white men. Cancer. 2006; 107: 75-82.
-
(2006)
Cancer
, vol.107
, pp. 75-82
-
-
Sanchez-Ortiz, R.F.1
Troncoso, P.2
Babaian, R.J.3
-
29
-
-
84924542708
-
African-American race is a predictor of seminal vesicle invasion after radical prostatectomy
-
Yamoah K, Walker A, Spangler E, et al. African-American race is a predictor of seminal vesicle invasion after radical prostatectomy. Clin Genitourin Cancer. 2015; 13: e65-72.
-
(2015)
Clin Genitourin Cancer
, vol.13
, pp. e65-e72
-
-
Yamoah, K.1
Walker, A.2
Spangler, E.3
-
30
-
-
84923328574
-
African American men with low-grade prostate cancer have increased disease recurrence after prostatectomy compared with Caucasian men
-
Yamoah K, Deville C, Vapiwala N, et al. African American men with low-grade prostate cancer have increased disease recurrence after prostatectomy compared with Caucasian men. Urol Oncol. 2015; 33: 70.e15-70.e22.
-
(2015)
Urol Oncol
, vol.33
, pp. 70.e15-70.e22
-
-
Yamoah, K.1
Deville, C.2
Vapiwala, N.3
-
31
-
-
84880803870
-
Genetic and molecular differences in prostate carcinogenesis between African American and Caucasian American men
-
Farrell J, Petrovics G, McLeod DG, et al. Genetic and molecular differences in prostate carcinogenesis between African American and Caucasian American men. Int J Mol Sci. 2013; 14: 15510-15531.
-
(2013)
Int J Mol Sci
, vol.14
, pp. 15510-15531
-
-
Farrell, J.1
Petrovics, G.2
McLeod, D.G.3
-
32
-
-
84885949199
-
Expression differences between African American and Caucasian prostate cancer tissue reveals that stroma is the site of aggressive changes
-
Kinseth MA, Jia Z, Rahmatpanah F, et al. Expression differences between African American and Caucasian prostate cancer tissue reveals that stroma is the site of aggressive changes. Int J Cancer. 2013; 134: 81-91.
-
(2013)
Int J Cancer
, vol.134
, pp. 81-91
-
-
Kinseth, M.A.1
Jia, Z.2
Rahmatpanah, F.3
-
33
-
-
84877936647
-
Genes associated with prostate cancer are differentially expressed in African American and European American men
-
Powell IJ, Dyson G, Land S, et al. Genes associated with prostate cancer are differentially expressed in African American and European American men. Cancer Epidemiol Biomarkers Prev. 2013; 22: 891-897.
-
(2013)
Cancer Epidemiol Biomarkers Prev
, vol.22
, pp. 891-897
-
-
Powell, I.J.1
Dyson, G.2
Land, S.3
-
34
-
-
60349099540
-
Microarray comparison of prostate tumor gene expression in African-American and Caucasian American males: A pilot project study
-
Reams RR, Agrawal D, Davis MB, et al. Microarray comparison of prostate tumor gene expression in African-American and Caucasian American males: A pilot project study. Infect Agent Cancer. 2009; 4: S3.
-
(2009)
Infect Agent Cancer
, vol.4
, pp. S3
-
-
Reams, R.R.1
Agrawal, D.2
Davis, M.B.3
-
35
-
-
85040379615
-
Differentially expressed genes in tumors of prostate cancer in American patients with European and African origin
-
Venkatesh K, Lajwanti D, Kiran SP, et al. Differentially expressed genes in tumors of prostate cancer in American patients with European and African origin. J Pharm Res. 2013; 6: 583-588.
-
(2013)
J Pharm Res
, vol.6
, pp. 583-588
-
-
Venkatesh, K.1
Lajwanti, D.2
Kiran, S.P.3
-
36
-
-
84877889086
-
Androgen receptor-target genes in African American prostate cancer disparities
-
Wang BD, Yang Q, Ceniccola K, et al. Androgen receptor-target genes in African American prostate cancer disparities. Prostate Cancer. 2013; 2013: 763569.
-
(2013)
Prostate Cancer
, vol.2013
-
-
Wang, B.D.1
Yang, Q.2
Ceniccola, K.3
-
37
-
-
38849190111
-
Tumor immunobiological differences in prostate cancer between African-American and European-American men
-
Wallace TA, Prueitt RL, Yi M, et al. Tumor immunobiological differences in prostate cancer between African-American and European-American men. Cancer Res. 2008; 68: 927-936.
-
(2008)
Cancer Res
, vol.68
, pp. 927-936
-
-
Wallace, T.A.1
Prueitt, R.L.2
Yi, M.3
-
38
-
-
0037498543
-
Black-white differences in survival from late-stage prostate cancer
-
Polednak AP. Black-white differences in survival from late-stage prostate cancer. Ethn Dis. 2003; 13: 220-225.
-
(2003)
Ethn Dis
, vol.13
, pp. 220-225
-
-
Polednak, A.P.1
-
39
-
-
77951808916
-
Racial differences in prostate cancer risk remain among US servicemen with equal access to care
-
Wells TS, Bukowinski AT, Smith TC, et al. Racial differences in prostate cancer risk remain among US servicemen with equal access to care. Prostate. 2010; 70: 727-734.
-
(2010)
Prostate
, vol.70
, pp. 727-734
-
-
Wells, T.S.1
Bukowinski, A.T.2
Smith, T.C.3
-
40
-
-
0345530846
-
Racial differences in mortality among Medicare recipients after treatment for localized prostate cancer
-
Godley PA, Schenck AP, Amamoo MA, et al. Racial differences in mortality among Medicare recipients after treatment for localized prostate cancer. J Natl Cancer Inst. 2003; 95: 1702-1710.
-
(2003)
J Natl Cancer Inst
, vol.95
, pp. 1702-1710
-
-
Godley, P.A.1
Schenck, A.P.2
Amamoo, M.A.3
-
41
-
-
84956945828
-
Differentially expressed genes and signature pathways of human prostate cancer
-
Myers JS, von Lersner AK, Robbins CJ, et al. Differentially expressed genes and signature pathways of human prostate cancer. PLoS One. 2015; 10: e0145322.
-
(2015)
PLoS One
, vol.10
-
-
Myers, J.S.1
von Lersner, A.K.2
Robbins, C.J.3
-
42
-
-
84912122995
-
Proteomic-coupled-network analysis of T877A-androgen receptor interactomes can predict clinical prostate cancer outcomes between white (non-Hispanic) and African-American groups
-
Zaman N, Giannopoulos PN, Chowdhury S, et al. Proteomic-coupled-network analysis of T877A-androgen receptor interactomes can predict clinical prostate cancer outcomes between white (non-Hispanic) and African-American groups. PLoS One. 2014; 9: e113190.
-
(2014)
PLoS One
, vol.9
-
-
Zaman, N.1
Giannopoulos, P.N.2
Chowdhury, S.3
-
43
-
-
84896445317
-
Race disparities in peptide profiles of North American and Kenyan Wilms tumor specimens
-
Libes JM, Seeley EH, Li M, et al. Race disparities in peptide profiles of North American and Kenyan Wilms tumor specimens. J Am Coll Surg. 2014; 218: 707-720.
-
(2014)
J Am Coll Surg
, vol.218
, pp. 707-720
-
-
Libes, J.M.1
Seeley, E.H.2
Li, M.3
-
44
-
-
84884733974
-
Quantitative proteomic analysis in HCV-induced HCC reveals sets of proteins with potential significance for racial disparity
-
Dillon ST, Bhasin MK, Feng X, et al. Quantitative proteomic analysis in HCV-induced HCC reveals sets of proteins with potential significance for racial disparity. J Transl Med. 2013; 11: 239-5876-11-239.
-
(2013)
J Transl Med
, vol.11
-
-
Dillon, S.T.1
Bhasin, M.K.2
Feng, X.3
-
45
-
-
67349266694
-
Universal sample preparation method for proteome analysis
-
Wisniewski JR, Zougman A, Nagaraj N, et al. Universal sample preparation method for proteome analysis. Nat Methods. 2009; 6: 359-362.
-
(2009)
Nat Methods
, vol.6
, pp. 359-362
-
-
Wisniewski, J.R.1
Zougman, A.2
Nagaraj, N.3
-
47
-
-
84874969184
-
PANTHER in 2013: Modeling the evolution of gene function, and other gene attributes, in the context of phylogenetic trees
-
Mi H, Muruganujan A, Thomas PD. PANTHER in 2013: Modeling the evolution of gene function, and other gene attributes, in the context of phylogenetic trees. Nucleic Acids Res. 2013; 41: D377-D386.
-
(2013)
Nucleic Acids Res
, vol.41
, pp. D377-D386
-
-
Mi, H.1
Muruganujan, A.2
Thomas, P.D.3
-
48
-
-
27344435774
-
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
-
Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005; 102: 15545-15550.
-
(2005)
Proc Natl Acad Sci U S A
, vol.102
, pp. 15545-15550
-
-
Subramanian, A.1
Tamayo, P.2
Mootha, V.K.3
-
49
-
-
58049215467
-
A novel signaling pathway impact analysis
-
Tarca AL, Draghici S, Khatri P, et al. A novel signaling pathway impact analysis. Bioinformatics. 2009; 25: 75-82.
-
(2009)
Bioinformatics
, vol.25
, pp. 75-82
-
-
Tarca, A.L.1
Draghici, S.2
Khatri, P.3
-
50
-
-
84878855445
-
Integrative pathway analysis of genome-wide association studies and gene expression data in prostate cancer
-
Jia P, Liu Y, Zhao Z. Integrative pathway analysis of genome-wide association studies and gene expression data in prostate cancer. BMC Syst Biol. 2012; 6 Suppl 3: S3-S13.
-
(2012)
BMC Syst Biol
, vol.6
, pp. S3-S13
-
-
Jia, P.1
Liu, Y.2
Zhao, Z.3
-
51
-
-
44349119764
-
Gene network and canonical pathway analysis in prostate cancer: A microarray study
-
Savli H, Szendroi A, Romics I, et al. Gene network and canonical pathway analysis in prostate cancer: A microarray study. Exp Mol Med. 2008; 40: 176-185.
-
(2008)
Exp Mol Med
, vol.40
, pp. 176-185
-
-
Savli, H.1
Szendroi, A.2
Romics, I.3
-
52
-
-
67049157979
-
Pathway biomarker profiling of localized and metastatic human prostate cancer reveal metastatic and prognostic signatures
-
Grubb RL, Deng J, Pinto PA, et al. Pathway biomarker profiling of localized and metastatic human prostate cancer reveal metastatic and prognostic signatures. J Proteome Res. 2009; 8: 3044-3054.
-
(2009)
J Proteome Res
, vol.8
, pp. 3044-3054
-
-
Grubb, R.L.1
Deng, J.2
Pinto, P.A.3
-
53
-
-
33645114908
-
Fatty acid synthase gene overexpression and copy number gain in prostate adenocarcinoma
-
Shah US, Dhir R, Gollin SM, et al. Fatty acid synthase gene overexpression and copy number gain in prostate adenocarcinoma. Hum Pathol. 2006; 37: 401-409.
-
(2006)
Hum Pathol
, vol.37
, pp. 401-409
-
-
Shah, U.S.1
Dhir, R.2
Gollin, S.M.3
-
54
-
-
4344707340
-
Molecular features of the transition from prostatic intraepithelial neoplasia (PIN) to prostate cancer: Genome-wide gene-expression profiles of prostate cancers and PINs
-
Ashida S, Nakagawa H, Katagiri T, et al. Molecular features of the transition from prostatic intraepithelial neoplasia (PIN) to prostate cancer: Genome-wide gene-expression profiles of prostate cancers and PINs. Cancer Res. 2004; 64: 5963-5972.
-
(2004)
Cancer Res
, vol.64
, pp. 5963-5972
-
-
Ashida, S.1
Nakagawa, H.2
Katagiri, T.3
-
55
-
-
0042429210
-
Fatty acid synthase expression defines distinct molecular signatures in prostate cancer
-
Rossi S, Graner E, Febbo P, et al. Fatty acid synthase expression defines distinct molecular signatures in prostate cancer. Mol Cancer Res. 2003; 1: 707-715.
-
(2003)
Mol Cancer Res
, vol.1
, pp. 707-715
-
-
Rossi, S.1
Graner, E.2
Febbo, P.3
-
56
-
-
0036497907
-
Overexpression of fatty acid synthase is an early and common event in the development of prostate cancer
-
Swinnen JV, Roskams T, Joniau S, et al. Overexpression of fatty acid synthase is an early and common event in the development of prostate cancer. Int J Cancer. 2002; 98: 19-22.
-
(2002)
Int J Cancer
, vol.98
, pp. 19-22
-
-
Swinnen, J.V.1
Roskams, T.2
Joniau, S.3
-
58
-
-
84963938401
-
Targeting fatty acid synthase with ASC-J9 suppresses proliferation and invasion of prostate cancer cells
-
[Epub ahead of print].
-
Wen S, Niu Y, Lee SO, et al. Targeting fatty acid synthase with ASC-J9 suppresses proliferation and invasion of prostate cancer cells. Mol Carcinog. 2016; [Epub ahead of print].
-
(2016)
Mol Carcinog
-
-
Wen, S.1
Niu, Y.2
Lee, S.O.3
-
59
-
-
63649099458
-
Fatty acid synthase: A metabolic enzyme and candidate oncogene in prostate cancer
-
Migita T, Ruiz S, Fornari A, et al. Fatty acid synthase: A metabolic enzyme and candidate oncogene in prostate cancer. J Natl Cancer Inst. 2009; 101: 519-532.
-
(2009)
J Natl Cancer Inst
, vol.101
, pp. 519-532
-
-
Migita, T.1
Ruiz, S.2
Fornari, A.3
-
60
-
-
44949244988
-
The pathogenesis of prostate cancer: From molecular to metabolic alterations
-
Benedettini E, Nguyen P, Loda M. The pathogenesis of prostate cancer: From molecular to metabolic alterations. Diagn Histopathol. 2008; 14: 195-201.
-
(2008)
Diagn Histopathol
, vol.14
, pp. 195-201
-
-
Benedettini, E.1
Nguyen, P.2
Loda, M.3
-
61
-
-
84958555054
-
The cancer-promoting gene fatty acid-binding protein 5 (FABP5) is epigenetically regulated during human prostate carcinogenesis
-
Kawaguchi K, Kinameri A, Suzuki S, et al. The cancer-promoting gene fatty acid-binding protein 5 (FABP5) is epigenetically regulated during human prostate carcinogenesis. Biochem J. 2016; 473: 449-461.
-
(2016)
Biochem J
, vol.473
, pp. 449-461
-
-
Kawaguchi, K.1
Kinameri, A.2
Suzuki, S.3
-
62
-
-
44449096722
-
Expression of cutaneous fatty acid-binding protein (C-FABP) in prostate cancer: Potential prognostic marker and target for tumourigenicity-suppression
-
Morgan EA, Forootan SS, Adamson J, et al. Expression of cutaneous fatty acid-binding protein (C-FABP) in prostate cancer: Potential prognostic marker and target for tumourigenicity-suppression. Int J Oncol. 2008; 32: 767-775.
-
(2008)
Int J Oncol
, vol.32
, pp. 767-775
-
-
Morgan, E.A.1
Forootan, S.S.2
Adamson, J.3
-
63
-
-
0037951788
-
High-level expression of cutaneous fatty acid-binding protein in prostatic carcinomas and its effect on tumorigenicity
-
Adamson J, Morgan EA, Beesley C, et al. High-level expression of cutaneous fatty acid-binding protein in prostatic carcinomas and its effect on tumorigenicity. Oncogene. 2003; 22: 2739-2749.
-
(2003)
Oncogene
, vol.22
, pp. 2739-2749
-
-
Adamson, J.1
Morgan, E.A.2
Beesley, C.3
-
64
-
-
50949128339
-
The emerging functions and mechanisms of mammalian fatty acid-binding proteins
-
Storch J, Corsico B. The emerging functions and mechanisms of mammalian fatty acid-binding proteins. Annu Rev Nutr. 2008; 28: 73-95.
-
(2008)
Annu Rev Nutr
, vol.28
, pp. 73-95
-
-
Storch, J.1
Corsico, B.2
-
65
-
-
0036291635
-
Selective cooperation between fatty acid binding proteins and peroxisome proliferator-activated receptors in regulating transcription
-
Tan N-, Shaw NS, Vinckenbosch N, et al. Selective cooperation between fatty acid binding proteins and peroxisome proliferator-activated receptors in regulating transcription. Mol Cell Biol. 2002; 22: 5114-5127.
-
(2002)
Mol Cell Biol
, vol.22
, pp. 5114-5127
-
-
Tan, N.1
Shaw, N.S.2
Vinckenbosch, N.3
-
66
-
-
84887425280
-
A novel cutaneous fatty acid-binding protein-related signaling pathway leading to malignant progression in prostate cancer cells
-
Bao Z, Malki MI, Forootan SS, et al. A novel cutaneous fatty acid-binding protein-related signaling pathway leading to malignant progression in prostate cancer cells. Genes Cancer. 2013; 4: 297-314.
-
(2013)
Genes Cancer
, vol.4
, pp. 297-314
-
-
Bao, Z.1
Malki, M.I.2
Forootan, S.S.3
-
67
-
-
84891907019
-
The expression of C-FABP and PPARgamma and their prognostic significance in prostate cancer
-
Forootan FS, Forootan SS, Malki MI, et al. The expression of C-FABP and PPARgamma and their prognostic significance in prostate cancer. Int J Oncol. 2014; 44: 265-275.
-
(2014)
Int J Oncol
, vol.44
, pp. 265-275
-
-
Forootan, F.S.1
Forootan, S.S.2
Malki, M.I.3
-
68
-
-
77956866143
-
Involvement of fatty acid binding protein 5 and PPARbeta/delta in prostate cancer cell growth
-
Morgan E, Kannan-Thulasiraman P, Noy N. Involvement of fatty acid binding protein 5 and PPARbeta/delta in prostate cancer cell growth. PPAR Res. 2010; 2010: 234629.
-
(2010)
PPAR Res
, vol.2010
-
-
Morgan, E.1
Kannan-Thulasiraman, P.2
Noy, N.3
-
69
-
-
73649114942
-
Profiling protein markers associated with lymph node metastasis in prostate cancer by DIGE-based proteomics analysis
-
Pang J, Liu WP, Liu XP, et al. Profiling protein markers associated with lymph node metastasis in prostate cancer by DIGE-based proteomics analysis. J Proteome Res. 2010; 9: 216-226.
-
(2010)
J Proteome Res
, vol.9
, pp. 216-226
-
-
Pang, J.1
Liu, W.P.2
Liu, X.P.3
-
70
-
-
0035360281
-
Human cutaneous fatty acid-binding protein induces metastasis by up-regulating the expression of vascular endothelial growth factor gene in rat Rama 37 model cells
-
Jing C, Beesley C, Foster CS, et al. Human cutaneous fatty acid-binding protein induces metastasis by up-regulating the expression of vascular endothelial growth factor gene in rat Rama 37 model cells. Cancer Res. 2001; 61: 4357-4364.
-
(2001)
Cancer Res
, vol.61
, pp. 4357-4364
-
-
Jing, C.1
Beesley, C.2
Foster, C.S.3
-
71
-
-
0034051501
-
Coordinate expression of cytokeratins 7and 20 in prostate adenocarcinoma and bladder urothelial carcinoma
-
Bassily NH, Vallorosi CJ, Akdas G, et al. Coordinate expression of cytokeratins 7and 20 in prostate adenocarcinoma and bladder urothelial carcinoma. Am J Clin Pathol. 2000; 113: 383-388.
-
(2000)
Am J Clin Pathol
, vol.113
, pp. 383-388
-
-
Bassily, N.H.1
Vallorosi, C.J.2
Akdas, G.3
-
72
-
-
0033711090
-
Immunophenotype of high-grade prostatic adenocarcinoma and urothelial carcinoma
-
Genega EM, Hutchinson B, Reuter VE, et al. Immunophenotype of high-grade prostatic adenocarcinoma and urothelial carcinoma. Mod Pathol. 2000; 13: 1186-1191.
-
(2000)
Mod Pathol
, vol.13
, pp. 1186-1191
-
-
Genega, E.M.1
Hutchinson, B.2
Reuter, V.E.3
-
73
-
-
0029013612
-
Coordinate expression of cytokeratins 7 and 20defines unique subsets of carcinomas
-
Wang NP, Zee S, Zarbo RJ, et al. Coordinate expression of cytokeratins 7 and 20defines unique subsets of carcinomas. Appl Immunohistochemistry. 1995; 3: 99-107.
-
(1995)
Appl Immunohistochemistry
, vol.3
, pp. 99-107
-
-
Wang, N.P.1
Zee, S.2
Zarbo, R.J.3
-
74
-
-
0028799310
-
Vimentin and cytokeratin expression in nodular hyperplasia and carcinoma of the prostate
-
Heatley M, Maxwell P, Whiteside C, et al. Vimentin and cytokeratin expression in nodular hyperplasia and carcinoma of the prostate. J Clin Pathol. 1995; 48: 1031-1034.
-
(1995)
J Clin Pathol
, vol.48
, pp. 1031-1034
-
-
Heatley, M.1
Maxwell, P.2
Whiteside, C.3
-
75
-
-
0033795923
-
Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: A survey of 435 cases
-
Chu P, Wu E, Weiss LM. Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: A survey of 435 cases. Mod Pathol. 2000; 13: 962-972.
-
(2000)
Mod Pathol
, vol.13
, pp. 962-972
-
-
Chu, P.1
Wu, E.2
Weiss, L.M.3
-
76
-
-
0036127901
-
Immunophenotypic characterization of 225 prostate adenocarcinomas with intermediate or high Gleason scores
-
Goldstein NS. Immunophenotypic characterization of 225 prostate adenocarcinomas with intermediate or high Gleason scores. Am J Clin Pathol. 2002; 117: 471-477.
-
(2002)
Am J Clin Pathol
, vol.117
, pp. 471-477
-
-
Goldstein, N.S.1
-
77
-
-
0036206309
-
Cytokeratins 20 and 7 as biomarkers: Usefulness in discriminating primary from metastatic adenocarcinoma
-
Tot T. Cytokeratins 20 and 7 as biomarkers: Usefulness in discriminating primary from metastatic adenocarcinoma. Eur J Cancer. 2002; 38: 758-763.
-
(2002)
Eur J Cancer
, vol.38
, pp. 758-763
-
-
Tot, T.1
-
79
-
-
0025177164
-
Differential cytokeratin expression in normal, hyperplastic and malignant epithelial cells from human prostate
-
Sherwood ER, Berg LA, Mitchell NJ, et al. Differential cytokeratin expression in normal, hyperplastic and malignant epithelial cells from human prostate. J Urol. 1990; 143: 167-171.
-
(1990)
J Urol
, vol.143
, pp. 167-171
-
-
Sherwood, E.R.1
Berg, L.A.2
Mitchell, N.J.3
-
80
-
-
77955084824
-
Aberrant expression of vimentin correlates with dedifferentiation and poor prognosis in patients with intrahepatic cholangiocarcinoma
-
Korita PV, Wakai T, Ajioka Y, et al. Aberrant expression of vimentin correlates with dedifferentiation and poor prognosis in patients with intrahepatic cholangiocarcinoma. Anticancer Res. 2010; 30: 2279-2285.
-
(2010)
Anticancer Res
, vol.30
, pp. 2279-2285
-
-
Korita, P.V.1
Wakai, T.2
Ajioka, Y.3
-
81
-
-
84872200824
-
Early events in cell adhesion and polarity during epithelial-mesenchymal transition
-
Huang RY, Guilford P, Thiery JP. Early events in cell adhesion and polarity during epithelial-mesenchymal transition. J Cell Sci. 2012; 125: 4417-4422.
-
(2012)
J Cell Sci
, vol.125
, pp. 4417-4422
-
-
Huang, R.Y.1
Guilford, P.2
Thiery, J.P.3
-
82
-
-
84927129326
-
The expression of epithelial-mesenchymal transition-related proteins in biliary epithelial cells is associated with liver fibrosis in biliary atresia
-
Xiao Y, Zhou Y, Chen Y, et al. The expression of epithelial-mesenchymal transition-related proteins in biliary epithelial cells is associated with liver fibrosis in biliary atresia. Pediatr Res. 2015; 77: 310-315.
-
(2015)
Pediatr Res
, vol.77
, pp. 310-315
-
-
Xiao, Y.1
Zhou, Y.2
Chen, Y.3
-
83
-
-
84963705448
-
ALDH1A3, a metabolic target for cancer diagnosis and therapy
-
[Epub ahead of print].
-
Duan J, Cai J, Guo Y, et al. ALDH1A3, a metabolic target for cancer diagnosis and therapy. Int J Cancer. 2016; [Epub ahead of print].
-
(2016)
Int J Cancer
-
-
Duan, J.1
Cai, J.2
Guo, Y.3
-
84
-
-
84929379752
-
MiR-187 targets the androgen-regulated gene ALDH1A3 in prostate cancer
-
Casanova-Salas I, Masia E, Arminan A, et al. MiR-187 targets the androgen-regulated gene ALDH1A3 in prostate cancer. PLoS One. 2015; 10: e0125576.
-
(2015)
PLoS One
, vol.10
-
-
Casanova-Salas, I.1
Masia, E.2
Arminan, A.3
-
85
-
-
34249687656
-
Androgen regulation of aldehyde dehydrogenase 1A3 (ALDH1A3) in the androgen-responsive human prostate cancer cell line LNCaP
-
Trasino SE, Harrison EH, Wang TT. Androgen regulation of aldehyde dehydrogenase 1A3 (ALDH1A3) in the androgen-responsive human prostate cancer cell line LNCaP. Exp Biol Med. 2007; 232: 762-771.
-
(2007)
Exp Biol Med
, vol.232
, pp. 762-771
-
-
Trasino, S.E.1
Harrison, E.H.2
Wang, T.T.3
-
86
-
-
84905514443
-
Essential role of aldehyde dehydrogenase 1A3 for the maintenance of non-small cell lung cancer stem cells is associated with the STAT3 pathway
-
Shao C, Sullivan JP, Girard L, et al. Essential role of aldehyde dehydrogenase 1A3 for the maintenance of non-small cell lung cancer stem cells is associated with the STAT3 pathway. Clin Cancer Res. 2014; 20: 4154-4166.
-
(2014)
Clin Cancer Res
, vol.20
, pp. 4154-4166
-
-
Shao, C.1
Sullivan, J.P.2
Girard, L.3
-
87
-
-
84866671365
-
ALDH1A isozymes are markers of human melanoma stem cells and potential therapeutic targets
-
Luo Y, Dallaglio K, Chen Y, et al. ALDH1A isozymes are markers of human melanoma stem cells and potential therapeutic targets. Stem Cells. 2012; 30: 2100-2113.
-
(2012)
Stem Cells
, vol.30
, pp. 2100-2113
-
-
Luo, Y.1
Dallaglio, K.2
Chen, Y.3
-
88
-
-
79951818699
-
Aldehyde dehydrogenase activity of breast cancer stem cells is primarily due to isoform ALDH1A3 and its expression is predictive of metastasis
-
Marcato P, Dean CA, Pan D, et al. Aldehyde dehydrogenase activity of breast cancer stem cells is primarily due to isoform ALDH1A3 and its expression is predictive of metastasis. Stem Cells. 2011; 29: 32-45.
-
(2011)
Stem Cells
, vol.29
, pp. 32-45
-
-
Marcato, P.1
Dean, C.A.2
Pan, D.3
-
89
-
-
57349114162
-
The cell-cell adhesion molecule E-cadherin
-
van Roy F, Berx G. The cell-cell adhesion molecule E-cadherin. Cell Mol Life Sci. 2008; 65: 3756-3788.
-
(2008)
Cell Mol Life Sci
, vol.65
, pp. 3756-3788
-
-
van Roy, F.1
Berx, G.2
-
90
-
-
0026795845
-
Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer
-
Umbas R, Schalken JA, Aalders TW, et al. Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer. Cancer Res. 1992; 52: 5104-5109.
-
(1992)
Cancer Res
, vol.52
, pp. 5104-5109
-
-
Umbas, R.1
Schalken, J.A.2
Aalders, T.W.3
-
91
-
-
0033744070
-
Expression of cadherins and catenins in paired tumor and non-neoplastic primary prostate cultures and corresponding prostatectomy specimens
-
Wang J, Krill D, Torbenson M, et al. Expression of cadherins and catenins in paired tumor and non-neoplastic primary prostate cultures and corresponding prostatectomy specimens. Urol Res. 2000; 28: 308-315.
-
(2000)
Urol Res
, vol.28
, pp. 308-315
-
-
Wang, J.1
Krill, D.2
Torbenson, M.3
-
92
-
-
77649132876
-
E-cadherin and beta-catenin loss of expression related to bone metastasis in prostate cancer
-
Pontes J, Jr, Srougi M, Borra PM, et al. E-cadherin and beta-catenin loss of expression related to bone metastasis in prostate cancer. Appl Immunohistochem Mol Morphol. 2010; 18: 179-184.
-
(2010)
Appl Immunohistochem Mol Morphol
, vol.18
, pp. 179-184
-
-
Pontes, J.1
Srougi, M.2
Borra, P.M.3
-
93
-
-
0032324792
-
Analysis of cathepsin D forms and their clinical implications in human prostate cancer
-
Cherry JP, Mordente JA, Chapman JR, et al. Analysis of cathepsin D forms and their clinical implications in human prostate cancer. J Urol. 1998; 160: 2223-2228.
-
(1998)
J Urol
, vol.160
, pp. 2223-2228
-
-
Cherry, J.P.1
Mordente, J.A.2
Chapman, J.R.3
-
94
-
-
77957001036
-
Potential biomarkers for differentiation of benign prostatic hyperplasia and prostate cancer
-
El Melegy NT, Aboulella HA, Abul-Fadl AM, et al. Potential biomarkers for differentiation of benign prostatic hyperplasia and prostate cancer. Br J Biomed Sci. 2010; 67: 109-112.
-
(2010)
Br J Biomed Sci
, vol.67
, pp. 109-112
-
-
El Melegy, N.T.1
Aboulella, H.A.2
Abul-Fadl, A.M.3
-
95
-
-
0036834245
-
Serum cathepsin D and its density in men with prostate cancer as new predictors of disease progression
-
Hara I, Miyake H, Yamanaka K, et al. Serum cathepsin D and its density in men with prostate cancer as new predictors of disease progression. Oncol Rep. 2002; 9: 1379-1383.
-
(2002)
Oncol Rep
, vol.9
, pp. 1379-1383
-
-
Hara, I.1
Miyake, H.2
Yamanaka, K.3
-
96
-
-
84875126913
-
Cathepsin D acts as an essential mediator to promote malignancy of benign prostatic epithelium
-
Pruitt FL, He Y, Franco OE, et al. Cathepsin D acts as an essential mediator to promote malignancy of benign prostatic epithelium. Prostate. 2013; 73: 476-488.
-
(2013)
Prostate
, vol.73
, pp. 476-488
-
-
Pruitt, F.L.1
He, Y.2
Franco, O.E.3
-
97
-
-
0037453706
-
MTA3, a mi-2/NuRD complex subunit, regulates an invasive growth pathway in breast cancer
-
Fujita N, Jaye DL, Kajita M, et al. MTA3, a mi-2/NuRD complex subunit, regulates an invasive growth pathway in breast cancer. Cell. 2003; 113: 207-219.
-
(2003)
Cell
, vol.113
, pp. 207-219
-
-
Fujita, N.1
Jaye, D.L.2
Kajita, M.3
-
98
-
-
0024805872
-
Overexpression and hormonal regulation of pro-cathepsin D in mammary and endometrial cancer
-
Rochefort H, Cavailles V, Augereau P, et al. Overexpression and hormonal regulation of pro-cathepsin D in mammary and endometrial cancer. J Steroid Biochem. 1989; 34: 177-182.
-
(1989)
J Steroid Biochem
, vol.34
, pp. 177-182
-
-
Rochefort, H.1
Cavailles, V.2
Augereau, P.3
-
99
-
-
84914150699
-
MTA family of proteins in prostate cancer: Biology, significance, and therapeutic opportunities
-
Levenson AS, Kumar A, Zhang X. MTA family of proteins in prostate cancer: Biology, significance, and therapeutic opportunities. Cancer Metastasis Rev. 2014; 33: 929-942.
-
(2014)
Cancer Metastasis Rev
, vol.33
, pp. 929-942
-
-
Levenson, A.S.1
Kumar, A.2
Zhang, X.3
-
100
-
-
0030271572
-
Macromolecular organization of basement membranes
-
Timpl R. Macromolecular organization of basement membranes. Curr Opin Cell Biol. 1996; 8: 618-624.
-
(1996)
Curr Opin Cell Biol
, vol.8
, pp. 618-624
-
-
Timpl, R.1
-
101
-
-
0034075654
-
Form and function: The laminin family of heterotrimers
-
Colognato H, Yurchenco PD. Form and function: The laminin family of heterotrimers. Dev Dyn. 2000; 218: 213-234.
-
(2000)
Dev Dyn
, vol.218
, pp. 213-234
-
-
Colognato, H.1
Yurchenco, P.D.2
-
102
-
-
72949119124
-
Integrins in cancer: Biological implications and therapeutic opportunities
-
Desgrosellier JS, Cheresh DA. Integrins in cancer: Biological implications and therapeutic opportunities. Nat Rev Cancer. 2010; 10: 9-22.
-
(2010)
Nat Rev Cancer
, vol.10
, pp. 9-22
-
-
Desgrosellier, J.S.1
Cheresh, D.A.2
-
103
-
-
53849143245
-
Integrins in prostate cancer progression
-
Goel HL, Li J, Kogan S, et al. Integrins in prostate cancer progression. Endocr Relat Cancer. 2008; 15: 657-664.
-
(2008)
Endocr Relat Cancer
, vol.15
, pp. 657-664
-
-
Goel, H.L.1
Li, J.2
Kogan, S.3
-
105
-
-
84873385587
-
Integrin signaling in cancer cell survival and chemoresistance
-
Aoudjit F, Vuori K. Integrin signaling in cancer cell survival and chemoresistance. Chemother Res Pract. 2012; 2012: 283181.
-
(2012)
Chemother Res Pract
, vol.2012
-
-
Aoudjit, F.1
Vuori, K.2
-
106
-
-
0027935370
-
Adhesion molecules, extracellular matrix, and proteases in prostate carcinoma
-
Nagle RB, Knox JD, Wolf C, et al. Adhesion molecules, extracellular matrix, and proteases in prostate carcinoma. J Cell Biochem Suppl. 1994; 19: 232-237.
-
(1994)
J Cell Biochem Suppl
, vol.19
, pp. 232-237
-
-
Nagle, R.B.1
Knox, J.D.2
Wolf, C.3
-
107
-
-
0028200873
-
Differential expression of extracellular matrix molecules and the alpha 6-integrins in the normal and neoplastic prostate
-
Knox JD, Cress AE, Clark V, et al. Differential expression of extracellular matrix molecules and the alpha 6-integrins in the normal and neoplastic prostate. Am J Pathol. 1994; 145: 167-174.
-
(1994)
Am J Pathol
, vol.145
, pp. 167-174
-
-
Knox, J.D.1
Cress, A.E.2
Clark, V.3
-
108
-
-
2642682426
-
In situ hybridization analysis of genes coding collagen IV alpha1 chain, laminin beta1 chain, and S-laminin in prostate tissue and prostate cancer: Increased basement membrane gene expression in high-grade and metastatic lesions
-
Pföhler C, Fixemer T, Jung V, et al. In situ hybridization analysis of genes coding collagen IV alpha1 chain, laminin beta1 chain, and S-laminin in prostate tissue and prostate cancer: Increased basement membrane gene expression in high-grade and metastatic lesions. Prostate. 1998; 36: 143-150.
-
(1998)
Prostate
, vol.36
, pp. 143-150
-
-
Pföhler, C.1
Fixemer, T.2
Jung, V.3
-
109
-
-
0030796362
-
Loss of type IV collagen alpha 5 and alpha 6 chains in human invasive prostate carcinomas
-
Dehan P, Waltregny D, Beschin A, et al. Loss of type IV collagen alpha 5 and alpha 6 chains in human invasive prostate carcinomas. Am J Pathol. 1997; 151: 1097-1104.
-
(1997)
Am J Pathol
, vol.151
, pp. 1097-1104
-
-
Dehan, P.1
Waltregny, D.2
Beschin, A.3
-
111
-
-
84879952909
-
Identification of new genes downregulated in prostate cancer and investigation of their effects on prognosis
-
Varisli L. Identification of new genes downregulated in prostate cancer and investigation of their effects on prognosis. Genet Test Mol Biomarkers. 2013; 17: 562-566.
-
(2013)
Genet Test Mol Biomarkers
, vol.17
, pp. 562-566
-
-
Varisli, L.1
-
112
-
-
0027537092
-
Differential expression of alpha 6 and alpha 2 very late antigen integrins in the normal, hyperplastic, and neoplastic prostate: Simultaneous demonstration of cell surface receptors and their extracellular ligands
-
Bonkhoff H, Stein U, Remberger K. Differential expression of alpha 6 and alpha 2 very late antigen integrins in the normal, hyperplastic, and neoplastic prostate: Simultaneous demonstration of cell surface receptors and their extracellular ligands. Hum Pathol. 1993; 24: 243-248.
-
(1993)
Hum Pathol
, vol.24
, pp. 243-248
-
-
Bonkhoff, H.1
Stein, U.2
Remberger, K.3
-
113
-
-
0028973409
-
The alpha 6 beta 1 and alpha 6 beta 4 integrins in human prostate cancer progression
-
Cress AE, Rabinovitz I, Zhu W, et al. The alpha 6 beta 1 and alpha 6 beta 4 integrins in human prostate cancer progression. Cancer Metastasis Rev. 1995; 14: 219-228.
-
(1995)
Cancer Metastasis Rev
, vol.14
, pp. 219-228
-
-
Cress, A.E.1
Rabinovitz, I.2
Zhu, W.3
-
114
-
-
0029024897
-
Expression of hemidesmosomal and extracellular matrix proteins by normal and malignant human prostate tissue
-
Nagle RB, Hao J, Knox JD, et al. Expression of hemidesmosomal and extracellular matrix proteins by normal and malignant human prostate tissue. Am J Pathol. 1995; 146: 1498-1507.
-
(1995)
Am J Pathol
, vol.146
, pp. 1498-1507
-
-
Nagle, R.B.1
Hao, J.2
Knox, J.D.3
-
115
-
-
84876586639
-
Targeting constitutively activated beta1 integrins inhibits prostate cancer metastasis
-
Lee YC, Jin JK, Cheng CJ, et al. Targeting constitutively activated beta1 integrins inhibits prostate cancer metastasis. Mol Cancer Res. 2013; 11: 405-417.
-
(2013)
Mol Cancer Res
, vol.11
, pp. 405-417
-
-
Lee, Y.C.1
Jin, J.K.2
Cheng, C.J.3
|